TPM1 and colorectal carcinoma: The luciferase reporter assay showed a reduction following transfection with miR-96 mimics and luciferase reporter plasmid containing the wild-type sequence of the 3′-untranslated region of TPM1; additionally, knockdown of miR-96 enhanced the chemosensitivity of CRC cells to oxaliplatin by targeting TPM1; in conclusion, miR-96 modulates oxaliplatin resistance in CRC cells[164].